MedBot (微创机器人)

Shang Hai Shi, China

Shanghai MicroPort® MedBot (Group) Co., Ltd., a robotics-specialized subsidiary of Shanghai MicroPort® Medical (Group) Co., Ltd. (00853.HK), commenced its development for laparoscopic surgery robots in 2014 (as an internal incubation project of MicroPort® group), and established a company in China in 2015 when its began to develop Toumai® Multi-port Laparoscopic Surgical Robot, Toumai® Single-port Laparoscopic Surgical Robot and SkyWalker® orthopedic surgical robot. We are committed to meeting the peak demand for robotic surgery. By integrating the cutting-edge research and robot ontology, control algorithms, electrical engineering, image-based navigation and precision imaging, we provide comprehensive intelligent surgical solutions to prolong and reshape the lives of patients, lead the maturity and development of robotic surgery, and shape the era of super intelligent surgery.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out MedBot (微创机器人) on @MedStartr Today #MedMo #MedStartrVentures

https://www.medstartr.ai/s/8IvpbswRr5g

Get Involved in MedBot (微创机器人)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2015
Website: medbotsurgical.com

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of MedBot (微创机器人)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.

Get Involved in MedBot (微创机器人)